tiprankstipranks
BioVaxys Technology (TSE:BIOV)
CNQX:BIOV

BioVaxys Technology (BIOV) Technical Analysis

14 Followers

Summary of all the Indicators

Overall Consensus
Sell
8Bullish
1Neutral
10Bearish
Technical Analysis Consensus
Buy
4Bullish
1Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
BioVaxys Technology’s (BIOV) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting BioVaxys Technology is a Sell.
BioVaxys Technology’s (BIOV) 20-Day exponential moving average is 0.07, while BioVaxys Technology’s (BIOV) share price is <C$0.1, making it a Sell.
BioVaxys Technology’s (BIOV) 50-Day exponential moving average is 0.07, while BioVaxys Technology’s (BIOV) share price is <C$0.1, making it a Sell.

BioVaxys Technology (BIOV) Pivot Points

Jun 15, 2024, 02:58 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.06
0.06
0.07
0.07
0.08
0.08
0.09
Fibonacci
0.06
0.07
0.07
0.07
0.08
0.08
0.08
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

BioVaxys Technology (BIOV) Moving Averages

Jun 15, 2024, 02:58 PM
Period
Simple
Exponential
MA5
0.07Sell
0.07Sell
MA10
0.07Buy
0.07Sell
MA20
0.07Sell
0.07Sell
MA50
0.07Sell
0.07Sell
MA100
0.07Sell
0.07Buy
MA200
0.05Buy
0.05Buy
BioVaxys Technology’s (BIOV) 10-Day exponential moving average is 0.07, while BioVaxys Technology’s (BIOV) share price is <C$0.1, making it a Sell.
BioVaxys Technology’s (BIOV) 100-Day exponential moving average is 0.07, while BioVaxys Technology’s (BIOV) share price is <C$0.1, making it a Buy.
BioVaxys Technology’s (BIOV) stock price is <C$0.1 and BioVaxys Technology’s (BIOV) 50-day simple moving average is 0.07, creating a Sell signal.
BioVaxys Technology’s (BIOV) stock price is <C$0.1 and BioVaxys Technology’s (BIOV) 100-day simple moving average is 0.07, creating a Sell signal.
BioVaxys Technology’s (BIOV) stock price is <C$0.1 and BioVaxys Technology’s (BIOV) 200-day simple moving average is 0.05, creating a Buy signal.

BioVaxys Technology (BIOV) Technical Indicators

Jun 15, 2024, 02:58 PM
Name
Value
Implied Action
RSI (14)
44.39
Neutral
STOCH (9,6)
0.00
-
STOCHRSI (14)
>-0.01
Buy
MACD (12,26)
>-0.01
Sell
ADX (14)
15.61
Buy
Williams %R
-100.00
Buy
CCI (14)
0.00
-
ATR (14)
<0.01
-
Ultimate Oscillator
1.89
Sell
ROC
0.00
-
BioVaxys Technology’s (BIOV) Relative Strength Index (RSI) is 44.39, creating a Neutral signal.
BioVaxys Technology’s (BIOV) Trend Strength Indicator (ADX) is 15.61, creating a Buy signal.

FAQ

Is BIOV a Buy, Hold, or Sell?
Based on BIOV’s technical indicators, BIOV is a Sell.
    What is BIOV’s RSI (14)?
    BIOV’s RSI (14) is 44.39, which suggests BIOV is a Neutral.
      What is BIOV’s MACD?
      BIOV’s MACD is >-0.01, which suggests BIOV is a Sell.
        What is BIOV’s 5-day moving average?
        BIOV’s 5-day moving average is 0.07, which suggests BIOV is a Sell.
          What is BIOV’s 20-day moving average?
          BIOV 20-day moving average is 0.07, which suggests BIOV is a Sell.
            What is BIOV’s 50-day moving average?
            BIOV’s 50-day moving average is 0.07, which suggests BIOV is a Sell.
              What is BIOV’s 200-day moving average?
              BIOV’s 200-day moving average is 0.05, which suggests BIOV is a Buy.
                What is BIOV’s Williams % R (14)?
                BIOV’s Williams % R (14) is -100.00, which suggests BIOV is a Buy.
                  What is BIOV’s CCI (14)?
                  Currently, no data Available
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis